Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Lilip Lau
AddedMar 31, 2024
UpdatedMay 31, 2026
Lilip Lau

Lilip Lau

Founder, Cavu Medical

CrunchbaseLinkedIn

Lilip Lau's Career

Cavu Medical
Cavu Medical

Palo Alto, CA, US

Founder
Paracor Medical
Paracor Medical

Sunnyvale, CA, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Lilip Lau's Career

Cavu Medical
Cavu Medical
5Palo Alto, CA, US
Founder

Similar to Cavu Medical

LuvauraLuvauraRaleigh, NC, USMedical Devicesest. 2018LuvauraRaleigh, NC, US · est. 2018

Innovative medical devices for vein treatment.

Angel · $125k5
VibryntVibryntMountain View, CA, USMedical Devicesest. 2006VibryntMountain View, CA, US · est. 2006

Vibrynt: Medical device innovator aiding weight loss through food consumption control.

Seed · $18.8M30
SatietySatietyPalo Alto, CA, USMedical Devicesest. 2000SatietyPalo Alto, CA, US · est. 2000

Satiety, Inc.: A US-based medical device company specializing in obesity treatment solutions.

Public · $71M30
Corveus MedicalCorveus MedicalHouston, TX, USMedical Devicesest. 2021Corveus MedicalHouston, TX, US · est. 2021

Corveus Medical: Innovating catheter-based nerve ablation for heart failure treatment.

Pre-Seed · $500k3
Paracor Medical
Paracor Medical
$74.5M751999Sunnyvale, CA, US
Founder

Leadership at Paracor Medical

William MavityWilliam MavityBoard Member
Michael B SweeneyMichael B SweeneyBoard Member

Similar to Paracor Medical

CormedicsCormedicsHouston, TX, USMedical Devicesest. 1989CormedicsHouston, TX, US · est. 1989

Cormedics Corp. is a medical device company innovating in cardiac treatments, focusing on rhythm management, atrial fibrillation, and targeted therapies.

Public · $1M2
ViacorViacorWilmington, MA, USMedical Devicesest. 1999ViacorWilmington, MA, US · est. 1999

Viacor: Innovating catheter-based solutions for heart valve diseases and CHF.

Series A · $34M30
Corisma MCS SystemsCorisma MCS SystemsHamden, CT, USMedical Devicesest. 2018Corisma MCS SystemsHamden, CT, US · est. 2018

CoRISMA MCS Systems: Innovating heart failure treatments with advanced medical devices.

Series A · $27M30
HospiHospiNewark, CA, USMedical Devicesest. 2012HospiNewark, CA, US · est. 2012

Hospi Corp: Innovating high-impact medical devices for enhanced patient comfort and cost reduction.

Series A · $4.8M15

People Similar to Lilip Lau

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · KakaoLouis Skip BaldinoLouis Skip BaldinoCEO · EndoGastric SolutionsChris TesoChris TesoCo-Founder · The GoodDavid HooperDavid HooperFounder · Minimus SpineShawn Shang-Lin TsaiShawn Shang-Lin TsaiCo-Founder · Ahead ProjectBrad SharpBrad SharpCEO · Integrated EndoscopyRajiv JainRajiv JainCo-Founder · Ever